Cargando…
Rab-mediated vesicle trafficking in cancer
A large group of small Rab GTPases which mediate secretory and endosomal membrane transport, as well as autophagosome biogenesis, are essential components of vesicle trafficking machinery. Specific Rab protein together with the cognate effectors coordinates the dynamics of trafficking pathway and de...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053131/ https://www.ncbi.nlm.nih.gov/pubmed/27716280 http://dx.doi.org/10.1186/s12929-016-0287-7 |
_version_ | 1782458356220297216 |
---|---|
author | Tzeng, Hong-Tai Wang, Yi-Ching |
author_facet | Tzeng, Hong-Tai Wang, Yi-Ching |
author_sort | Tzeng, Hong-Tai |
collection | PubMed |
description | A large group of small Rab GTPases which mediate secretory and endosomal membrane transport, as well as autophagosome biogenesis, are essential components of vesicle trafficking machinery. Specific Rab protein together with the cognate effectors coordinates the dynamics of trafficking pathway and determines the cargo proteins destination. Functional impairments of Rab proteins by mutations or post-translational modifications disrupting the regulatory network of vesicle trafficking have been implicated in tumorigenesis. Therefore, the vesicle transport regulators play essential roles in the mediation of cancer cell biology, including uncontrolled cell growth, invasion and metastasis. The context-dependent role of the same Rab to act as either an oncoprotein or tumor suppressor in different cancers is found. Such discrepancies may be due in part to the interaction of specific Rab protein with different effectors or cargos in various tumors. Here, we review recent advances in the roles of Rab GTPases in communicating with other effectors in tumor progression. In this review, we also emphasize dysregulation of Rab-mediated membrane delivery shifting normal cell behaviors toward malignancy. Thus, recovery of the dysregulated vesicle trafficking systems in cancer cells may provide future directions for potential strategy to restrain tumor progression. |
format | Online Article Text |
id | pubmed-5053131 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-50531312016-10-06 Rab-mediated vesicle trafficking in cancer Tzeng, Hong-Tai Wang, Yi-Ching J Biomed Sci Review A large group of small Rab GTPases which mediate secretory and endosomal membrane transport, as well as autophagosome biogenesis, are essential components of vesicle trafficking machinery. Specific Rab protein together with the cognate effectors coordinates the dynamics of trafficking pathway and determines the cargo proteins destination. Functional impairments of Rab proteins by mutations or post-translational modifications disrupting the regulatory network of vesicle trafficking have been implicated in tumorigenesis. Therefore, the vesicle transport regulators play essential roles in the mediation of cancer cell biology, including uncontrolled cell growth, invasion and metastasis. The context-dependent role of the same Rab to act as either an oncoprotein or tumor suppressor in different cancers is found. Such discrepancies may be due in part to the interaction of specific Rab protein with different effectors or cargos in various tumors. Here, we review recent advances in the roles of Rab GTPases in communicating with other effectors in tumor progression. In this review, we also emphasize dysregulation of Rab-mediated membrane delivery shifting normal cell behaviors toward malignancy. Thus, recovery of the dysregulated vesicle trafficking systems in cancer cells may provide future directions for potential strategy to restrain tumor progression. BioMed Central 2016-10-06 /pmc/articles/PMC5053131/ /pubmed/27716280 http://dx.doi.org/10.1186/s12929-016-0287-7 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Review Tzeng, Hong-Tai Wang, Yi-Ching Rab-mediated vesicle trafficking in cancer |
title | Rab-mediated vesicle trafficking in cancer |
title_full | Rab-mediated vesicle trafficking in cancer |
title_fullStr | Rab-mediated vesicle trafficking in cancer |
title_full_unstemmed | Rab-mediated vesicle trafficking in cancer |
title_short | Rab-mediated vesicle trafficking in cancer |
title_sort | rab-mediated vesicle trafficking in cancer |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053131/ https://www.ncbi.nlm.nih.gov/pubmed/27716280 http://dx.doi.org/10.1186/s12929-016-0287-7 |
work_keys_str_mv | AT tzenghongtai rabmediatedvesicletraffickingincancer AT wangyiching rabmediatedvesicletraffickingincancer |